We have attempted to characterize the
5-hydroxytryptamine (5-HT) receptors mediating bronchoconstriction, vasodilatation, vasodepression and
tachycardia in anaesthetized cats following bilateral vagosympathectomy and beta-
adrenoceptor blockade with
propranolol.
5-HT (1-100 micrograms/kg-1 i.v.) caused dose-related bronchoconstriction and
tachycardia but variable and complex effects on diastolic blood pressure and carotid arterial vascular resistance. In contrast,
5-carboxamidotryptamine (5-CT; 0.01-1 micrograms kg-1 i.v.) caused consistent, dose-related decreases in diastolic blood pressure and carotid arterial vascular resistance and increases in heart rate. 5-CT did not cause bronchoconstriction. The 5-HT-induced bronchoconstriction was dose-dependently antagonized by
methiothepin,
methysergide and
ketanserin (10-100 micrograms kg-1 i.v.). The highest doses used of these antagonists did not antagonize bronchoconstriction induced by
prostaglandin F2 alpha. The high potency of all three antagonists indicate a 5-HT2-receptor mediated effect. The 5-HT- and 5-CT-induced
tachycardia as well as the 5-CT-induced vasodepressor and carotid arterial
vasodilator responses were dose-dependently antagonized by low doses of
methiothepin (10-100 micrograms kg-1 i.v.) and by high doses of
methysergide (100-1000 micrograms kg-1 i.v.) but were little affected by
ketanserin in doses up to 1000 micrograms kg-1 i.v. These selective effects of 5-CT appear to be mediated by '5-HT1-like' receptors.